Lataa...
Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD
In April 2010, the European Medicines Agency Committee for Medicinal Products for Human Use recommended approval of roflumilast, a selective phosphodiesterase 4 inhibitor, for the “maintenance treatment of severe chronic obstructive pulmonary disease (COPD, FEV(1) postbronchodilator less than 50% pr...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2915539/ https://ncbi.nlm.nih.gov/pubmed/20689641 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|